COVID-19 has precipitated significant policy changes to many health and social welfare services. One of these is opioid pharmacotherapy for the treatment of opioid dependence. In this seminar, we describe our detailed analysis of policy making under conditions of emergency. 14 key insights are provided. Routine policy-making processes do not serve as effective structures for policy making in times of crisis. New forms, people and processes need to be mobilised to respond rapidly and effectively. Innovation is key. Yet what is also clear is that we need innovation (and better policy) every day. Waiting for the next crisis to mobilise better policy making is not a solution.
Authors:
Dr Richard Mellor
Prof Matthew Kearnes
Dr Kari Lancaster
Dr Laura McLauchlan
Prof Alison Ritter
Professor Alison Ritter AO is a drug policy scholar and Director of the Drug Policy Modelling Program at UNSW Sydney. She conducts research on drug laws, drug treatment, models and methods of democratic participation in drug policy; and research focussed on policy process. Her work is supported by grants from competitive research funding bodies (NHMRC, ARC) as well as commissioned research from governments across Australia.
Register through Eventbrite now, and you will be sent the Zoom link to this event before the start.
Need assistance to register for this seminar? Ring +612 9385 7800.
